Vigonvita Life Sciences Co., Ltd. (02630.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 77.40

From 52W high−35.88%

Volume101400.00

Market capHKD 14.02B

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

HKD 77.40

From 52W high

−35.88%

Volume

101400.00

Market cap

HKD 14.02B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

47.0

MomentumView details →

1D Return

+8.39%

YTD Return

+2.44%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+8.39%

YTD Return

+2.44%

1Y Return

—

RSI (14)

47.0

vs 50D SMA

−4.11%

vs 200D SMA

−1.75%

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

Wangshan Wangshui-B (02630.HK) announced interim results for the six months ended June 2026, with revenue of RMB 132 million, up 693.7% year-on-year, and a narrowed loss of RMB 122 million versus a loss of RMB 173 million in the prior-year period.23d ago

Similar companies

通化东宝600867.SH 奥瑞德600666.SH Metacare Co., Ltd.118000.KS Luye Pharma Group Ltd.02186.HK Tdspharm464280.KQ 广誉远600771.SH Find similar companies →

Latest newsMore news →

Wangshan Wangshui-B (02630.HK) announced interim results for the six months ended June 2026, with revenue of RMB 132 million, up 693.7% year-on-year, and a narrowed loss of RMB 122 million versus a loss of RMB 173 million in the prior-year period.23d ago